Uterine fibroids
Uterine fibroids (leiomyomas or myomas) are benign smooth muscle tumours of the uterus.
They affect up to 70% of women by age 50 and, although non-cancerous, can cause significant morbidity depending on their size, number, and location.
โจ Presentation is highly variable, from asymptomatic cases to severe menstrual disturbance and reproductive complications.
๐งฉ Types of Fibroids
- Intramural: Within the uterine wall โ most common, often causes menorrhagia and bulk symptoms.
- Submucosal: Beneath the endometrium โ heavy menstrual bleeding + infertility risk.
- Subserosal: Beneath the serosa โ may grow large, pressing on bladder/bowel.
- Pedunculated: Attached by a stalk โ risk of torsion and acute pain.
- Cervical: Arise from cervix โ may cause obstruction or pressure symptoms.
โ ๏ธ Risk Factors
- ๐ต Age: Peak 30โ50 years.
- ๐งฌ Family History: Increased risk if first-degree relatives affected.
- ๐ Ethnicity: More common and earlier onset in African-Caribbean women.
- ๐ Hormonal: Oestrogen + progesterone promote growth โ shrink after menopause.
- โ๏ธ Obesity: Adipose tissue โ oestrogen levels.
- ๐ซ Nulliparity: Never pregnant = higher risk.
๐ฉบ Clinical Features
- ๐ Menorrhagia: Heavy/prolonged periods (especially submucosal fibroids).
- ๐ฃ Pelvic Pressure: "Dragging" or fullness sensation.
- ๐ฝ Urinary Symptoms: Frequency, retention (due to bladder compression).
- ๐ฉ Bowel Symptoms: Constipation from rectal pressure.
- โค๏ธโ๐ฅ Dyspareunia: Painful intercourse, esp. cervical fibroids.
- ๐ถ Reproductive Issues: Infertility, miscarriage, malpresentation, obstructed labour.
- โก Acute Pain: Due to red degeneration (esp. in pregnancy) or torsion of pedunculated fibroid.
- Exam: Enlarged, irregular "lumpy" uterus on bimanual exam; abdominal mass if large.
๐ Investigations
- ๐ค Ultrasound (TV/TA): First-line to assess size, site, and number.
- ๐งฒ MRI: For surgical planning or complex cases.
- ๐ฆ Hysteroscopy: Direct visualisation + removal of submucosal fibroids.
- ๐ง Sonohysterography: Saline-infusion scan highlights cavity distortion.
๐ Medical Management
- ๐ฉน NSAIDs: Symptom relief, โ pain (no effect on fibroid size).
- ๐ Hormonal Therapy:
- COCP โ regulates bleeding.
- Mirena (LNG-IUS) โ โ menorrhagia, preserves fertility.
- GnRH Agonists (e.g., leuprolide) โ temporary shrinkage, useful pre-op or peri-menopause.
- ๐ Selective Progesterone Receptor Modulators (e.g., Ulipristal): Shrinks fibroids + controls bleeding.
๐ช Surgical & Interventional Options
- โ๏ธ Myomectomy: Removes fibroids, uterus preserved โ fertility maintained.
- ๐ฅ Hysterectomy: Definitive option for severe cases, no fertility preservation.
- ๐ฉธ Uterine Artery Embolization (UAE): Cuts off fibroid blood supply โ shrinkage. Not recommended if fertility desired.
- ๐ฅ Endometrial Ablation: For menorrhagia + small submucosal fibroids; not fertility-preserving.
- ๐ฏ MR-guided Focused Ultrasound: Non-invasive thermal destruction under MRI guidance.
๐ Complications
- ๐ Iron-Deficiency Anaemia: From chronic menorrhagia.
- ๐ถ Infertility & Miscarriage: Submucosal fibroids distort uterine cavity.
- ๐คฐ Pregnancy Complications: Malpresentation, obstructed labour, preterm labour.
- โก Red Degeneration: Painful necrosis, esp. in pregnancy.
- ๐ฝ Urinary Retention / Recurrent UTIs: From bladder compression.
โ
Key Exam Pearls
- Fibroids are oestrogen-dependent โ shrink after menopause.
- Most common type: intramural.
- Most symptomatic for bleeding: submucosal.
- Definitive treatment: hysterectomy.